Indefinite Delivery Contract SPE2DR25D1931

Award Date 8/1/25
Last Date to Order 12/31/36
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The federal contract IDV award SPE2DR25D3110 is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,999,999,999, provides a comprehensive range of pharmaceutical products and medical supplies to support global military healthcare programs through December 2036. This IDC serves as the primary contracting vehicle for the DLA...
The federal contract IDV award, SPE2DR25D1992, is a single-award Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $999,999,999, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and has an ultimate completion date of December 31, 2036. The contract's purpose is to establish a Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) to provide...
The federal contract IDV award SPE2DU25D7051 is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,999,999,999, aims to establish a Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) to provide worldwide pharmaceutical support to various DoD customers, including the Defense Health...
The federal contract IDV award is for an Indefinite Delivery Contract (IDC) between the Defense Logistics Agency (DLA) Troop Support Medical and Amerisourcebergen Drug Corp. The contract, valued at $999,999,999, has a period of performance running through December 2036 and provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract aims to establish Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN...
The federal contract IDV award, valued at $999,999,999, was granted by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract serves as a Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) to provide worldwide pharmaceutical support, including brand-name, generic, and specialty medications, as well as related medical supplies, to the Defense Health Agency, Department of Defense,...
The subject federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $9,999,999,999, has an ultimate completion date of December 31, 2036 and provides worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency, Department of Defense, United States Coast Guard, and US...
The federal contract IDV award SPE2DR25D2911 is a single-award Indefinite Delivery Contract (IDC) between the Defense Logistics Agency (DLA) Troop Support Medical and Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $999,999,999 and a performance period through December 2036. The contract aims to establish a Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) that will provide worldwide pharmaceutical support, including brand-name,...
The federal contract IDV award is for an Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $999,999,999, provides worldwide pharmaceutical support to various Department of Defense (DoD) customers, including the Defense Health Agency, the U.S. Coast Guard, and U.S. Naval Fleet. The contract covers a broad...
The federal contract IDV award SPE2DR25D3010 is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $999,999,999 IDC has an ultimate completion date of December 31, 2026 and serves as a prime vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
The federal contract IDV award is an Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,999,999,999, has an ultimate completion date of December 31, 2036 and was awarded on November 13, 2025. The purpose of this IDC is to establish Pharmaceutical Prime Vendor Global Program Generation V contracts to...

The federal contract IDV award SPE2DR25D1931 is an Indefinite Delivery Contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,999,999,999, has an ultimate completion date of December 31, 2036 and provides worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency, U.S. Coast Guard, and U.S. Naval Fleet.

The contract aims to establish Prime Vendor Contracts for the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), which will cover a comprehensive range of pharmaceutical products and medical supplies, including brand-name and generic drugs, specialty medications, vaccines, syringes, vials, and test kits across multiple therapeutic areas. The procurement is an unrestricted, fully competitive acquisition using a Lowest Price Technically Acceptable (LPTA) evaluation method, with the intention to make multiple regional awards to at least three different contractors. The contract has a 30-month base period with three 30-month option periods, and the estimated total value across all regions and options is $30.3 billion.

Generated 6/6/25, 9:43 AM